Efficacy of PCIA with oxycodone mixed with dexmedetomidine for analgesia after combined pancreas-kidney transplantation
Xiangyang Yu, Lili Jia, Wenli Yu, Hongyin Du
Abstract
Xiangyang Yu, Lili Jia, Wenli Yu, Hongyin Du
Abstract
Objective To evaluate the efficacy of patient-controlled intravenous anesthesia(PCIA)with oxycodone mixed with dexmedetomidine for analgesia after combined pancreas-kidney transplantation. Methods Forty American Society of Anesthesiologists physical status Ⅱ or Ⅲ patients, aged 18-64 yr, weighing 40-100 kg, scheduled for elective combined allogeneic pancreas-kidney transplantation, were randomly divided into 2 groups(n=20 each): sufentanil group(group S)and oxycodone combined with dexmedetomidine group(group OD). PCIA was performed at the end of surgery.PCIA solution contained sufentanil 2.0 μg/kg and tropisetron 5 mg in 100 ml of normal saline in group S, and oxycodone 0.6 mg/kg, dexmedetomidine 0.48 μg/kg and tropisetron 5 mg in 100 ml of normal saline in group OD.The PCIA pump was set up with a 0.5 ml bolus dose, a 15 min lockout interval and background infusion at a rate of 2 ml/h.Ramsay sedation score and visual analog scale score were recorded at 4, 12, 24 and 48 h after surgery.The development and degree of agitation were recorded within 48 h after surgery.The development of adverse reactions such as nausea and vomiting, pruritus and respiratory depression was recorded.Venous blood samples were collected at 12 and 24 h after surgery for determination of serum blood urea nitrogen, creatinine and cystatin C concentrations, and the urine volume was calculated. Results Compared with group S, visual analog scale score was significantly decreased, Ramsay sedation score was increased, the rate of satisfactory sedation was increased, the incidence of agitation, nausea and vomiting was decreased, the serum blood urea nitrogen, creatinine and cystatin C concentrations were decreased, and the urine volume was increased at each time point after surgery(P 0.05). Conclusion PCIA with oxycodone mixed with dexmedetomidine provides reliable efficacy and higher safety when used for analgesia after combined pancreas-kidney transplantation and is helpful in promoting recovery of the function of the transplanted kidney. Key words: Dexmedetomidine; Oxycodone; Analgesia, patient-controlled; Kidney transplantation; Pancreas transplantation
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the efficacy of patient-controlled intravenous anesthesia(PCIA)with oxycodone mixed with dexmedetomidine for analgesia after combined pancreas-kidney transplantation. Methods Forty American Society of Anesthesiologists physical status Ⅱ or Ⅲ patients, aged 18-64 yr, weighing 40-100 kg, scheduled for elective combined allogeneic pancreas-kidney transplantation, were randomly divided into 2 groups(n=20 each): sufentanil group(group S)and oxycodone combined with dexmedetomidine group(group OD). PCIA was performed at the end of surgery.PCIA solution contained sufentanil 2.0 μg/kg and tropisetron 5 mg in 100 ml of normal saline in group S, and oxycodone 0.6 mg/kg, dexmedetomidine 0.48 μg/kg and tropisetron 5 mg in 100 ml of normal saline in group OD.The PCIA pump was set up with a 0.5 ml bolus dose, a 15 min lockout interval and background infusion at a rate of 2 ml/h.Ramsay sedation score and visual analog scale score were recorded at 4, 12, 24 and 48 h after surgery.The development and degree of agitation were recorded within 48 h after surgery.The development of adverse reactions such as nausea and vomiting, pruritus and respiratory depression was recorded.Venous blood samples were collected at 12 and 24 h after surgery for determination of serum blood urea nitrogen, creatinine and cystatin C concentrations, and the urine volume was calculated. Results Compared with group S, visual analog scale score was significantly decreased, Ramsay sedation score was increased, the rate of satisfactory sedation was increased, the incidence of agitation, nausea and vomiting was decreased, the serum blood urea nitrogen, creatinine and cystatin C concentrations were decreased, and the urine volume was increased at each time point after surgery(P 0.05). Conclusion PCIA with oxycodone mixed with dexmedetomidine provides reliable efficacy and higher safety when used for analgesia after combined pancreas-kidney transplantation and is helpful in promoting recovery of the function of the transplanted kidney. Key words: Dexmedetomidine; Oxycodone; Analgesia, patient-controlled; Kidney transplantation; Pancreas transplantation
Key concepts: Dexmedetomidine, Medicine, Anesthesia, Sedation, Tropisetron, Sufentanil, Oxycodone, Visual analogue scale